nodes	percent_of_prediction	percent_of_DWPC	metapath
Trametinib—MAP2K2—Signaling by SCF-KIT—KRAS—gallbladder cancer	0.000637	0.000637	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by ERBB4—EGFR—gallbladder cancer	0.000635	0.000635	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by Insulin receptor—HRAS—gallbladder cancer	0.000633	0.000633	CbGpPWpGaD
Trametinib—MAP2K1—VEGFA-VEGFR2 Pathway—HRAS—gallbladder cancer	0.000631	0.000631	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by SCF-KIT—EGFR—gallbladder cancer	0.00063	0.00063	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by Interleukins—HRAS—gallbladder cancer	0.000627	0.000627	CbGpPWpGaD
Trametinib—MAP2K1—Downstream signal transduction—NRAS—gallbladder cancer	0.000622	0.000622	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by FGFR—NRAS—gallbladder cancer	0.000619	0.000619	CbGpPWpGaD
Trametinib—MAP2K2—Fc epsilon receptor (FCERI) signaling—NRAS—gallbladder cancer	0.000617	0.000617	CbGpPWpGaD
Trametinib—MAP2K2—DAP12 interactions—NRAS—gallbladder cancer	0.000617	0.000617	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by FGFR in disease—NRAS—gallbladder cancer	0.000617	0.000617	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by ERBB2—NRAS—gallbladder cancer	0.000616	0.000616	CbGpPWpGaD
Trametinib—MAP2K1—DAP12 signaling—NRAS—gallbladder cancer	0.000613	0.000613	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by EGFR—NRAS—gallbladder cancer	0.000611	0.000611	CbGpPWpGaD
Trametinib—MAP2K2—Downstream signaling of activated FGFR—KRAS—gallbladder cancer	0.000609	0.000609	CbGpPWpGaD
Trametinib—MAP2K2—Regulation of Actin Cytoskeleton—KRAS—gallbladder cancer	0.000609	0.000609	CbGpPWpGaD
Trametinib—MAP2K2—Downstream signal transduction—EGFR—gallbladder cancer	0.000606	0.000606	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by EGFR in Cancer—NRAS—gallbladder cancer	0.000606	0.000606	CbGpPWpGaD
Trametinib—MAP2K1—Downstream signaling of activated FGFR—EGFR—gallbladder cancer	0.000603	0.000603	CbGpPWpGaD
Trametinib—MAP2K1—Regulation of Actin Cytoskeleton—EGFR—gallbladder cancer	0.000603	0.000603	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by FGFR—EGFR—gallbladder cancer	0.000603	0.000603	CbGpPWpGaD
Trametinib—MAP2K2—EGF/EGFR Signaling Pathway—EGFR—gallbladder cancer	0.000603	0.000603	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by PDGF—NRAS—gallbladder cancer	0.000603	0.000603	CbGpPWpGaD
Trametinib—MAP2K1—MAPK Signaling Pathway—NRAS—gallbladder cancer	0.000602	0.000602	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by ERBB2—EGFR—gallbladder cancer	0.0006	0.0006	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by ERBB4—KRAS—gallbladder cancer	0.000599	0.000599	CbGpPWpGaD
Trametinib—MAP2K2—DAP12 signaling—EGFR—gallbladder cancer	0.000597	0.000597	CbGpPWpGaD
Trametinib—MAP2K2—TGF-beta Signaling Pathway—TP53—gallbladder cancer	0.000596	0.000596	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by VEGF—HRAS—gallbladder cancer	0.000596	0.000596	CbGpPWpGaD
Trametinib—MAP2K2—PDGFR-beta signaling pathway—HRAS—gallbladder cancer	0.000596	0.000596	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by SCF-KIT—KRAS—gallbladder cancer	0.000596	0.000596	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by ERBB4—EGFR—gallbladder cancer	0.000594	0.000594	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by Insulin receptor—HRAS—gallbladder cancer	0.000592	0.000592	CbGpPWpGaD
Trametinib—MAP2K2—MAPK Signaling Pathway—EGFR—gallbladder cancer	0.000586	0.000586	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—ERBB4—gallbladder cancer	0.000581	0.000581	CbGpPWpGaD
Trametinib—MAP2K1—Fc epsilon receptor (FCERI) signaling—NRAS—gallbladder cancer	0.000577	0.000577	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by FGFR in disease—NRAS—gallbladder cancer	0.000577	0.000577	CbGpPWpGaD
Trametinib—MAP2K1—DAP12 interactions—NRAS—gallbladder cancer	0.000577	0.000577	CbGpPWpGaD
Trametinib—MAP2K2—Downstream signal transduction—KRAS—gallbladder cancer	0.000573	0.000573	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by EGFR—NRAS—gallbladder cancer	0.000572	0.000572	CbGpPWpGaD
Trametinib—MAP2K1—Downstream signaling of activated FGFR—KRAS—gallbladder cancer	0.00057	0.00057	CbGpPWpGaD
Trametinib—MAP2K1—Regulation of Actin Cytoskeleton—KRAS—gallbladder cancer	0.00057	0.00057	CbGpPWpGaD
Trametinib—MAP2K2—EGF/EGFR Signaling Pathway—KRAS—gallbladder cancer	0.00057	0.00057	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by FGFR—KRAS—gallbladder cancer	0.00057	0.00057	CbGpPWpGaD
Trametinib—MAP2K1—Downstream signal transduction—EGFR—gallbladder cancer	0.000567	0.000567	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by ERBB2—KRAS—gallbladder cancer	0.000567	0.000567	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by EGFR in Cancer—NRAS—gallbladder cancer	0.000567	0.000567	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by FGFR—EGFR—gallbladder cancer	0.000564	0.000564	CbGpPWpGaD
Trametinib—MAP2K1—EGF/EGFR Signaling Pathway—EGFR—gallbladder cancer	0.000564	0.000564	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by PDGF—NRAS—gallbladder cancer	0.000564	0.000564	CbGpPWpGaD
Trametinib—MAP2K2—DAP12 signaling—KRAS—gallbladder cancer	0.000564	0.000564	CbGpPWpGaD
Trametinib—MAP2K2—DAP12 interactions—EGFR—gallbladder cancer	0.000562	0.000562	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by FGFR in disease—EGFR—gallbladder cancer	0.000562	0.000562	CbGpPWpGaD
Trametinib—MAP2K2—Fc epsilon receptor (FCERI) signaling—EGFR—gallbladder cancer	0.000562	0.000562	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by ERBB2—EGFR—gallbladder cancer	0.000561	0.000561	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by ERBB4—KRAS—gallbladder cancer	0.000561	0.000561	CbGpPWpGaD
Trametinib—MAP2K1—DAP12 signaling—EGFR—gallbladder cancer	0.000559	0.000559	CbGpPWpGaD
Trametinib—MAP2K1—TGF-beta Signaling Pathway—TP53—gallbladder cancer	0.000558	0.000558	CbGpPWpGaD
Trametinib—MAP2K1—PDGFR-beta signaling pathway—HRAS—gallbladder cancer	0.000557	0.000557	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by EGFR—EGFR—gallbladder cancer	0.000557	0.000557	CbGpPWpGaD
Trametinib—MAP2K2—MAPK Signaling Pathway—KRAS—gallbladder cancer	0.000553	0.000553	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by NGF—ERBB2—gallbladder cancer	0.000552	0.000552	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by EGFR in Cancer—EGFR—gallbladder cancer	0.000552	0.000552	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by PDGF—EGFR—gallbladder cancer	0.000549	0.000549	CbGpPWpGaD
Trametinib—MAP2K1—MAPK Signaling Pathway—EGFR—gallbladder cancer	0.000548	0.000548	CbGpPWpGaD
Trametinib—MAP2K2—NGF signalling via TRKA from the plasma membrane—NRAS—gallbladder cancer	0.000546	0.000546	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—ERBB4—gallbladder cancer	0.000544	0.000544	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by SCF-KIT—HRAS—gallbladder cancer	0.000541	0.000541	CbGpPWpGaD
Trametinib—MAP2K1—Downstream signal transduction—KRAS—gallbladder cancer	0.000536	0.000536	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by FGFR—KRAS—gallbladder cancer	0.000533	0.000533	CbGpPWpGaD
Trametinib—MAP2K1—EGF/EGFR Signaling Pathway—KRAS—gallbladder cancer	0.000533	0.000533	CbGpPWpGaD
Trametinib—MAP2K2—BDNF signaling pathway—HRAS—gallbladder cancer	0.000532	0.000532	CbGpPWpGaD
Trametinib—MAP2K2—Focal Adhesion—EGFR—gallbladder cancer	0.000531	0.000531	CbGpPWpGaD
Trametinib—MAP2K2—Fc epsilon receptor (FCERI) signaling—KRAS—gallbladder cancer	0.000531	0.000531	CbGpPWpGaD
Trametinib—MAP2K2—DAP12 interactions—KRAS—gallbladder cancer	0.000531	0.000531	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by FGFR in disease—KRAS—gallbladder cancer	0.000531	0.000531	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by ERBB2—KRAS—gallbladder cancer	0.00053	0.00053	CbGpPWpGaD
Trametinib—MAP2K1—DAP12 signaling—KRAS—gallbladder cancer	0.000528	0.000528	CbGpPWpGaD
Trametinib—MAP2K2—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—gallbladder cancer	0.000528	0.000528	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by EGFR—KRAS—gallbladder cancer	0.000526	0.000526	CbGpPWpGaD
Trametinib—MAP2K1—Fc epsilon receptor (FCERI) signaling—EGFR—gallbladder cancer	0.000526	0.000526	CbGpPWpGaD
Trametinib—MAP2K1—DAP12 interactions—EGFR—gallbladder cancer	0.000526	0.000526	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by FGFR in disease—EGFR—gallbladder cancer	0.000526	0.000526	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by EGFR in Cancer—KRAS—gallbladder cancer	0.000521	0.000521	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by EGFR—EGFR—gallbladder cancer	0.000521	0.000521	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by PDGF—KRAS—gallbladder cancer	0.000519	0.000519	CbGpPWpGaD
Trametinib—MAP2K2—Downstream signaling of activated FGFR—HRAS—gallbladder cancer	0.000518	0.000518	CbGpPWpGaD
Trametinib—MAP2K1—MAPK Signaling Pathway—KRAS—gallbladder cancer	0.000518	0.000518	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by NGF—ERBB2—gallbladder cancer	0.000517	0.000517	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by EGFR in Cancer—EGFR—gallbladder cancer	0.000516	0.000516	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by PDGF—EGFR—gallbladder cancer	0.000514	0.000514	CbGpPWpGaD
Trametinib—MAP2K1—NGF signalling via TRKA from the plasma membrane—NRAS—gallbladder cancer	0.000511	0.000511	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by ERBB4—HRAS—gallbladder cancer	0.00051	0.00051	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by SCF-KIT—HRAS—gallbladder cancer	0.000506	0.000506	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—ERBB3—gallbladder cancer	0.000502	0.000502	CbGpPWpGaD
Trametinib—MAP2K2—Axon guidance—ERBB2—gallbladder cancer	0.0005	0.0005	CbGpPWpGaD
Trametinib—MAP2K1—BDNF signaling pathway—HRAS—gallbladder cancer	0.000498	0.000498	CbGpPWpGaD
Trametinib—MAP2K2—NGF signalling via TRKA from the plasma membrane—EGFR—gallbladder cancer	0.000498	0.000498	CbGpPWpGaD
Trametinib—MAP2K1—Focal Adhesion—EGFR—gallbladder cancer	0.000497	0.000497	CbGpPWpGaD
Trametinib—MAP2K1—DAP12 interactions—KRAS—gallbladder cancer	0.000497	0.000497	CbGpPWpGaD
Trametinib—MAP2K1—Fc epsilon receptor (FCERI) signaling—KRAS—gallbladder cancer	0.000497	0.000497	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by FGFR in disease—KRAS—gallbladder cancer	0.000497	0.000497	CbGpPWpGaD
Trametinib—MAP2K1—Integrated Pancreatic Cancer Pathway—EGFR—gallbladder cancer	0.000495	0.000495	CbGpPWpGaD
Trametinib—MAP2K1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—gallbladder cancer	0.000494	0.000494	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by EGFR—KRAS—gallbladder cancer	0.000492	0.000492	CbGpPWpGaD
Trametinib—MAP2K2—MAPK Signaling Pathway—TP53—gallbladder cancer	0.000492	0.000492	CbGpPWpGaD
Trametinib—MAP2K2—Insulin Signaling—HRAS—gallbladder cancer	0.000489	0.000489	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by EGFR in Cancer—KRAS—gallbladder cancer	0.000488	0.000488	CbGpPWpGaD
Trametinib—MAP2K2—Downstream signal transduction—HRAS—gallbladder cancer	0.000487	0.000487	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by PDGF—KRAS—gallbladder cancer	0.000486	0.000486	CbGpPWpGaD
Trametinib—MAP2K1—Downstream signaling of activated FGFR—HRAS—gallbladder cancer	0.000484	0.000484	CbGpPWpGaD
Trametinib—MAP2K2—EGF/EGFR Signaling Pathway—HRAS—gallbladder cancer	0.000484	0.000484	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by FGFR—HRAS—gallbladder cancer	0.000484	0.000484	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by ERBB2—HRAS—gallbladder cancer	0.000482	0.000482	CbGpPWpGaD
Trametinib—MAP2K2—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—gallbladder cancer	0.000481	0.000481	CbGpPWpGaD
Trametinib—MAP2K2—DAP12 signaling—HRAS—gallbladder cancer	0.00048	0.00048	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by ERBB4—HRAS—gallbladder cancer	0.000477	0.000477	CbGpPWpGaD
Trametinib—MAP2K2—NGF signalling via TRKA from the plasma membrane—KRAS—gallbladder cancer	0.00047	0.00047	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—ERBB3—gallbladder cancer	0.00047	0.00047	CbGpPWpGaD
Trametinib—MAP2K1—Axon guidance—ERBB2—gallbladder cancer	0.000468	0.000468	CbGpPWpGaD
Trametinib—MAP2K1—Integrated Pancreatic Cancer Pathway—KRAS—gallbladder cancer	0.000467	0.000467	CbGpPWpGaD
Trametinib—MAP2K1—NGF signalling via TRKA from the plasma membrane—EGFR—gallbladder cancer	0.000466	0.000466	CbGpPWpGaD
Trametinib—MAP2K1—MAPK Signaling Pathway—TP53—gallbladder cancer	0.00046	0.00046	CbGpPWpGaD
Trametinib—MAP2K1—Insulin Signaling—HRAS—gallbladder cancer	0.000458	0.000458	CbGpPWpGaD
Trametinib—MAP2K1—Downstream signal transduction—HRAS—gallbladder cancer	0.000455	0.000455	CbGpPWpGaD
Trametinib—MAP2K2—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—gallbladder cancer	0.000454	0.000454	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by FGFR—HRAS—gallbladder cancer	0.000453	0.000453	CbGpPWpGaD
Trametinib—MAP2K1—EGF/EGFR Signaling Pathway—HRAS—gallbladder cancer	0.000453	0.000453	CbGpPWpGaD
Trametinib—MAP2K2—Fc epsilon receptor (FCERI) signaling—HRAS—gallbladder cancer	0.000451	0.000451	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by FGFR in disease—HRAS—gallbladder cancer	0.000451	0.000451	CbGpPWpGaD
Trametinib—MAP2K2—DAP12 interactions—HRAS—gallbladder cancer	0.000451	0.000451	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by ERBB2—HRAS—gallbladder cancer	0.000451	0.000451	CbGpPWpGaD
Trametinib—MAP2K1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—gallbladder cancer	0.00045	0.00045	CbGpPWpGaD
Trametinib—MAP2K1—DAP12 signaling—HRAS—gallbladder cancer	0.000449	0.000449	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by EGFR—HRAS—gallbladder cancer	0.000447	0.000447	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by EGFR in Cancer—HRAS—gallbladder cancer	0.000443	0.000443	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by PDGF—HRAS—gallbladder cancer	0.000441	0.000441	CbGpPWpGaD
Trametinib—MAP2K1—NGF signalling via TRKA from the plasma membrane—KRAS—gallbladder cancer	0.00044	0.00044	CbGpPWpGaD
Trametinib—MAP2K2—Cytokine Signaling in Immune system—NRAS—gallbladder cancer	0.000427	0.000427	CbGpPWpGaD
Trametinib—MAP2K2—Focal Adhesion—HRAS—gallbladder cancer	0.000426	0.000426	CbGpPWpGaD
Trametinib—MAP2K1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—gallbladder cancer	0.000425	0.000425	CbGpPWpGaD
Trametinib—MAP2K1—DAP12 interactions—HRAS—gallbladder cancer	0.000422	0.000422	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by FGFR in disease—HRAS—gallbladder cancer	0.000422	0.000422	CbGpPWpGaD
Trametinib—MAP2K1—Fc epsilon receptor (FCERI) signaling—HRAS—gallbladder cancer	0.000422	0.000422	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by NGF—NRAS—gallbladder cancer	0.00042	0.00042	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by EGFR—HRAS—gallbladder cancer	0.000418	0.000418	CbGpPWpGaD
Trametinib—MAP2K1—Integrated Pancreatic Cancer Pathway—TP53—gallbladder cancer	0.000415	0.000415	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by EGFR in Cancer—HRAS—gallbladder cancer	0.000415	0.000415	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by PDGF—HRAS—gallbladder cancer	0.000413	0.000413	CbGpPWpGaD
Trametinib—MAP2K1—Cytokine Signaling in Immune system—NRAS—gallbladder cancer	0.0004	0.0004	CbGpPWpGaD
Trametinib—MAP2K2—NGF signalling via TRKA from the plasma membrane—HRAS—gallbladder cancer	0.0004	0.0004	CbGpPWpGaD
Trametinib—MAP2K1—Focal Adhesion—HRAS—gallbladder cancer	0.000399	0.000399	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by NGF—NRAS—gallbladder cancer	0.000393	0.000393	CbGpPWpGaD
Trametinib—MAP2K2—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—gallbladder cancer	0.000386	0.000386	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by NGF—EGFR—gallbladder cancer	0.000383	0.000383	CbGpPWpGaD
Trametinib—MAP2K2—Axon guidance—NRAS—gallbladder cancer	0.00038	0.00038	CbGpPWpGaD
Trametinib—MAP2K1—NGF signalling via TRKA from the plasma membrane—HRAS—gallbladder cancer	0.000374	0.000374	CbGpPWpGaD
Trametinib—MAP2K2—Cytokine Signaling in Immune system—KRAS—gallbladder cancer	0.000368	0.000368	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by NGF—KRAS—gallbladder cancer	0.000362	0.000362	CbGpPWpGaD
Trametinib—MAP2K1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—gallbladder cancer	0.000361	0.000361	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by NGF—EGFR—gallbladder cancer	0.000358	0.000358	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—ERBB2—gallbladder cancer	0.000357	0.000357	CbGpPWpGaD
Trametinib—MAP2K1—Axon guidance—NRAS—gallbladder cancer	0.000356	0.000356	CbGpPWpGaD
Trametinib—MAP2K2—Axon guidance—EGFR—gallbladder cancer	0.000346	0.000346	CbGpPWpGaD
Trametinib—MAP2K1—Cytokine Signaling in Immune system—KRAS—gallbladder cancer	0.000344	0.000344	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—ERBB4—gallbladder cancer	0.000338	0.000338	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by NGF—KRAS—gallbladder cancer	0.000338	0.000338	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—ERBB2—gallbladder cancer	0.000334	0.000334	CbGpPWpGaD
Trametinib—MAP2K2—Axon guidance—KRAS—gallbladder cancer	0.000327	0.000327	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—BCL2—gallbladder cancer	0.000324	0.000324	CbGpPWpGaD
Trametinib—MAP2K1—Axon guidance—EGFR—gallbladder cancer	0.000324	0.000324	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—ERBB4—gallbladder cancer	0.000317	0.000317	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—ERBB2—gallbladder cancer	0.000315	0.000315	CbGpPWpGaD
Trametinib—MAP2K2—Cytokine Signaling in Immune system—HRAS—gallbladder cancer	0.000313	0.000313	CbGpPWpGaD
Trametinib—MAP2K2—Disease—ERBB4—gallbladder cancer	0.000312	0.000312	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by NGF—HRAS—gallbladder cancer	0.000307	0.000307	CbGpPWpGaD
Trametinib—MAP2K1—Axon guidance—KRAS—gallbladder cancer	0.000306	0.000306	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—BCL2—gallbladder cancer	0.000303	0.000303	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—ERBB2—gallbladder cancer	0.000295	0.000295	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—ERBB3—gallbladder cancer	0.000293	0.000293	CbGpPWpGaD
Trametinib—MAP2K1—Cytokine Signaling in Immune system—HRAS—gallbladder cancer	0.000292	0.000292	CbGpPWpGaD
Trametinib—MAP2K1—Disease—ERBB4—gallbladder cancer	0.000292	0.000292	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by NGF—HRAS—gallbladder cancer	0.000288	0.000288	CbGpPWpGaD
Trametinib—MAP2K2—Axon guidance—HRAS—gallbladder cancer	0.000278	0.000278	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—ERBB3—gallbladder cancer	0.000274	0.000274	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—NRAS—gallbladder cancer	0.000271	0.000271	CbGpPWpGaD
Trametinib—MAP2K2—Disease—ERBB3—gallbladder cancer	0.00027	0.00027	CbGpPWpGaD
Trametinib—MAP2K1—Axon guidance—HRAS—gallbladder cancer	0.00026	0.00026	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—NRAS—gallbladder cancer	0.000254	0.000254	CbGpPWpGaD
Trametinib—MAP2K1—Disease—ERBB3—gallbladder cancer	0.000253	0.000253	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—EGFR—gallbladder cancer	0.000247	0.000247	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—NRAS—gallbladder cancer	0.00024	0.00024	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—KRAS—gallbladder cancer	0.000233	0.000233	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—EGFR—gallbladder cancer	0.000231	0.000231	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—NRAS—gallbladder cancer	0.000224	0.000224	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—ERBB4—gallbladder cancer	0.000219	0.000219	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—KRAS—gallbladder cancer	0.000218	0.000218	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—EGFR—gallbladder cancer	0.000218	0.000218	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—KRAS—gallbladder cancer	0.000206	0.000206	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—ERBB4—gallbladder cancer	0.000205	0.000205	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—EGFR—gallbladder cancer	0.000204	0.000204	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—HRAS—gallbladder cancer	0.000198	0.000198	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—KRAS—gallbladder cancer	0.000193	0.000193	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—ERBB3—gallbladder cancer	0.000189	0.000189	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—BCL2—gallbladder cancer	0.000189	0.000189	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—HRAS—gallbladder cancer	0.000186	0.000186	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—ERBB2—gallbladder cancer	0.000183	0.000183	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—ERBB3—gallbladder cancer	0.000177	0.000177	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—BCL2—gallbladder cancer	0.000177	0.000177	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—HRAS—gallbladder cancer	0.000175	0.000175	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—ERBB2—gallbladder cancer	0.000172	0.000172	CbGpPWpGaD
Trametinib—MAP2K2—Disease—ERBB2—gallbladder cancer	0.000169	0.000169	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—HRAS—gallbladder cancer	0.000164	0.000164	CbGpPWpGaD
Trametinib—MAP2K1—Disease—ERBB2—gallbladder cancer	0.000158	0.000158	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—NRAS—gallbladder cancer	0.000153	0.000153	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—NRAS—gallbladder cancer	0.000143	0.000143	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—NRAS—gallbladder cancer	0.00014	0.00014	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—EGFR—gallbladder cancer	0.000139	0.000139	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—KRAS—gallbladder cancer	0.000131	0.000131	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—NRAS—gallbladder cancer	0.000131	0.000131	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—EGFR—gallbladder cancer	0.00013	0.00013	CbGpPWpGaD
Trametinib—MAP2K2—Disease—NRAS—gallbladder cancer	0.000129	0.000129	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—EGFR—gallbladder cancer	0.000127	0.000127	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—KRAS—gallbladder cancer	0.000123	0.000123	CbGpPWpGaD
Trametinib—MAP2K1—Disease—NRAS—gallbladder cancer	0.000121	0.000121	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—KRAS—gallbladder cancer	0.00012	0.00012	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—EGFR—gallbladder cancer	0.000119	0.000119	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—ERBB2—gallbladder cancer	0.000119	0.000119	CbGpPWpGaD
Trametinib—MAP2K2—Disease—EGFR—gallbladder cancer	0.000117	0.000117	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—KRAS—gallbladder cancer	0.000112	0.000112	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—HRAS—gallbladder cancer	0.000112	0.000112	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—ERBB2—gallbladder cancer	0.000111	0.000111	CbGpPWpGaD
Trametinib—MAP2K2—Disease—KRAS—gallbladder cancer	0.000111	0.000111	CbGpPWpGaD
Trametinib—MAP2K1—Disease—EGFR—gallbladder cancer	0.00011	0.00011	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—HRAS—gallbladder cancer	0.000105	0.000105	CbGpPWpGaD
Trametinib—MAP2K1—Disease—KRAS—gallbladder cancer	0.000104	0.000104	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—HRAS—gallbladder cancer	0.000102	0.000102	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—HRAS—gallbladder cancer	9.55e-05	9.55e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—HRAS—gallbladder cancer	9.43e-05	9.43e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—NRAS—gallbladder cancer	9.02e-05	9.02e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—HRAS—gallbladder cancer	8.82e-05	8.82e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—NRAS—gallbladder cancer	8.44e-05	8.44e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—EGFR—gallbladder cancer	8.22e-05	8.22e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—KRAS—gallbladder cancer	7.77e-05	7.77e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—EGFR—gallbladder cancer	7.69e-05	7.69e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—KRAS—gallbladder cancer	7.27e-05	7.27e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—TP53—gallbladder cancer	6.9e-05	6.9e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—HRAS—gallbladder cancer	6.6e-05	6.6e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—TP53—gallbladder cancer	6.46e-05	6.46e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—HRAS—gallbladder cancer	6.18e-05	6.18e-05	CbGpPWpGaD
